… The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and
morbidity after anterior myocardial infarction. N Engl J Med.1995; 332:80-85. Crossref…

… An ACE Inhibitor … ACE inhibitors in patients with acute myocardial infarction. One of the
group’s initial decisions was to categorize the ACE inhibitor trials of myocardial infarction into …

… ACE inhibitors were prescribed … ACE inhibitors in patients with myocardial infarction with
increasing frequency. Those patients with the greatest expected benefit receive ACE inhibitor …

… to ACE inhibitors, only 68% were prescribed an ACE inhibitor at … , are better tolerated
than ACE inhibitors. Since both drugs … reduce mortality and prevent myocardial infarction (MI). …

… as effective as angiotensin-converting enzyme inhibitors on the risk of myocardial infarction,
… slightly more protective than angiotensin-converting enzyme inhibitors on the risk of stroke. …

… myocardial infarction receive an ACE inhibitor … of ACE inhibition during and after myocardial
infarction and the differences between the trials. In any event, treatment with an ACEinhibitor…

… Clinical trials have documented that initiation of ACE inhibitor treatment early after myocardial
infarction saves 5 lives/1,000 patients treated in the first month.8, 9, 10, 11, 12 If ACC/AHA …

… that giving angiotensin converting enzyme inhibitors after myocardial infarction reduces left
… focuson the effects of angiotensin converting enzyme inhibitorson mortality and morbidity …

… We support the selective use of ACE inhibitor therapy in patients after AMI. Initiation within
the early hours of the myocardial infarction before the patient is clinically stable remains …

… , angiotensin-converting enzyme (ACE) inhibitors appear to … trials using ACE inhibitors in
patients with MI, and summarize … on the use of ACE inhibitors in pa tients with MI based on the …